rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2005-11-8
|
pubmed:abstractText |
Seladin-1 (from selective Alzheimer's disease indicator-1) is a recently discovered gene that has been found to be down-regulated in brain regions affected by Alzheimer's disease. Seladin-1 effectively protects neurons against beta-amyloid-mediated toxicity and prevents apoptosis via inhibition of the activation of caspase-3, a key mediator of the apoptotic cascade. Although seladin-1 is expressed in the pituitary gland, no study addressed the expression or the function of this gene in pituitary adenomas.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CASP3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Caspases,
http://linkedlifedata.com/resource/pubmed/chemical/DHCR24 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Human Growth Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Octreotide,
http://linkedlifedata.com/resource/pubmed/chemical/Oxidoreductases Acting on CH-CH...,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Somatostatin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0021-972X
|
pubmed:author |
pubmed-author:AmmannatiFrancoF,
pubmed-author:BaglioniSilvanaS,
pubmed-author:BenvenutiSusannaS,
pubmed-author:CellaiIlariaI,
pubmed-author:FerranteEmanueleE,
pubmed-author:GelminiStefaniaS,
pubmed-author:LaniaAndreaA,
pubmed-author:LucianiPaolaP,
pubmed-author:MantovaniGiovannaG,
pubmed-author:PeriAlessandroA,
pubmed-author:SerioMarioM,
pubmed-author:SpadaAnnaA
|
pubmed:issnType |
Print
|
pubmed:volume |
90
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6156-61
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16091489-Adenoma,
pubmed-meshheading:16091489-Adolescent,
pubmed-meshheading:16091489-Adult,
pubmed-meshheading:16091489-Apoptosis,
pubmed-meshheading:16091489-Caspase 3,
pubmed-meshheading:16091489-Caspases,
pubmed-meshheading:16091489-Female,
pubmed-meshheading:16091489-Human Growth Hormone,
pubmed-meshheading:16091489-Humans,
pubmed-meshheading:16091489-Male,
pubmed-meshheading:16091489-Middle Aged,
pubmed-meshheading:16091489-Nerve Tissue Proteins,
pubmed-meshheading:16091489-Octreotide,
pubmed-meshheading:16091489-Oxidoreductases Acting on CH-CH Group Donors,
pubmed-meshheading:16091489-Pituitary Neoplasms,
pubmed-meshheading:16091489-RNA, Messenger,
pubmed-meshheading:16091489-Receptors, Somatostatin
|
pubmed:year |
2005
|
pubmed:articleTitle |
Expression of the antiapoptotic gene seladin-1 and octreotide-induced apoptosis in growth hormone-secreting and nonfunctioning pituitary adenomas.
|
pubmed:affiliation |
Endocrine Unit, Department of Clinical Physiopathology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|